OPANA ER Adverse Event: Microangiopathic haemolytic anaemia
OPANA ER Adverse Event: Microangiopathic haemolytic anaemia is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: OPANA ER; Product category: Drug; Primary reaction: Microangiopathic haemolytic anaemia.
| Primary drug | OPANA ER |
|---|---|
| Product category | Drug |
| Primary reaction | Microangiopathic haemolytic anaemia |
| All reactions | Microangiopathic haemolytic anaemia; Thrombotic microangiopathy; Renal failure acute; Drug abuse; Polysubstance dependence |
| Seriousness | Serious |
| Patient outcome | Unknown |
| Patient sex | Male |
| All drugs reported | OPANA ER; OXYCODONE HCL |
| Reporter country | US |
| Reporter type | 1 |
| Report date | 20140311 |
| Report ID | 10007273 |
$299/mo
Try FDATracker →